Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Cannabis Stocks CGC, ACB, TLRY, SNDL Already Fading Despite German Legalization

By Dana Blankenhorn, InvestorPlace Contributor
It’s hard to see cannabis stocks and companies making a lot of money if legalization isn’t followed by effective regulation and enforcement.

Why Is Sintx Technologies (SINT) Stock Down 31% Today?

By William White, InvestorPlace Writer
Sintx Technologies stock is falling on Friday as investors prepare for more details about a proposed public offering of SINT Shares.

3 Stocks Under $5 Ready to Outpace the Market

By Yiannis Zourmpanos, InvestorPlace Contributor
Discover three stocks under $5 from SaaS transformation to biotech advancements, that showcase immense potential for market outperformance.

Amazon’s AI Awakening: Why AMZN Stock Is the Magnificent Seven’s Sleeping Giant

By Louis Navellier and the InvestorPlace Research Staff
While garnering relatively less attention than its "Magnificent Seven" peers, AMZN stock is a top buy among this elite set of tech stocks.

3 Penny Stocks With the Power to 10X Your $1K Investment

By Alex Sirois, InvestorPlace Contributor
The 10X penny stocks discussed here are a much more reliable investment than many other alternatives investors are likely to encounter.

7 High-Value Stocks With Massive Wealth-Building Potential

By Yiannis Zourmpanos, InvestorPlace Contributor
Explore high-value stocks shaping the future across semiconductors, digital payments, AI, and healthcare for savvy investors.

The 5 Biggest Buyers of Canopy Growth (CGC) Stock

By Eddie Pan, InvestorPlace Financial News Writer
CGC stock is getting lit up after the German government legalized marijuana. Let's take a look at the company's top buyers during Q4.

Hot Stocks: The 3 Best Opportunities for Retirement Investing

By Jeremy Flint, InvestorPlace Contributor
If you have retirement investing on the mind, adding these retirement stocks to your portfolio will help prepare for your golden years.

TLRY Stock Alert: Tilray Just Got a Germany-Sized Boost

By Chris MacDonald, InvestorPlace Contributor
Tilray's existing presence in Germany is boding well for TLRY stock, which is up more than 16% on news of partial legalization in Germany.

Wall Street’s Favorite Long-Term Stocks? 3 Names That Could Make You Filthy Rich

By Faizan Farooque, InvestorPlace Contributor
Wall Street's favorite long-term stocks JNJ, KO, and CAT offer a blend of dividend reliability, sector diversity, and strong market presence

Hot Stocks: The 3 Best Opportunities for Investing in Biotech 

By Chandler Capital, InvestorPlace Contributor
Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now.

3 Stocks That Could Be the Next Big Thing in Gene Editing

By Ian Cooper, InvestorPlace Contributor
Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks.

7 Stocks to Own in the Run-Up to the Presidential Election

By Josh Enomoto, InvestorPlace Contributor
While political cycles are always difficult to predict, the challenge of finding stocks for the presidential election is slightly easier. How can that be, you…

Dear 3M Stock Fans, Mark Your Calendars for April 1

By Shrey Dua, InvestorPlace Senior Financial News Reporter
Investors are split on MMM stock ahead of 3M's long-awaited healthcare spinoff, Solventum, launching April 1.

3 Groundbreaking Stocks Set to Redefine the Market

By Yiannis Zourmpanos, InvestorPlace Contributor
Explore how groundbreaking stocks transform leisure, passenger ground transportation, and health care services.

3 Under-the-Radar Stocks to Transform $10K into $100K by 2028

By Yiannis Zourmpanos, InvestorPlace Contributor
Uncover the the valuation potential of under-the-radar stocks operating in application software, pharmaceuticals, and managed healthcare.

Wall Street’s Favorite Cannabis Stocks? 3 Names That Could Make You Filthy Rich

By Will Ashworth, InvestorPlace Contributor
Recent news has investors more interested in Wall Street’s favorite cannabis stocks. Here are three momentum plays.

3 Nightmare Nasdaq Stocks Not Worth Holding Another Day

By Rick Orford, InvestorPlace Contributor
Selling these three NASDAQ stocks might be the best option now, as they continue to show potential issues and continued weakness.

Why Does Canopy Growth (CGC) Stock Keep Climbing This Week?

By Josh Enomoto, InvestorPlace Contributor
With marijuana reform being pushed at the highest level, Canopy Growth is looking like a clear beneficiary as CGC stock attempts a comeback.
Load More Articles